To further examine the influence of GAS5 expression level on prognosis of AML-NK patients, we decided to investigate the expression level of miR-222, a micro-RNA whose oncogenic function is known to be involved in GAS5 expression and function. This evidence concerns the gene GAS5 and acute myeloid leukemia.